Phio Pharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Phio Pharmaceuticals Corp. (PHIO)

1.04 -0.04 (-3.70%) USD | NASDAQ | Jan 21, 16:00

1.04 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for PHIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Tharimmune, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--
Oragenics, Inc.	--